Study highlights need for integration of policy, behavior change, and risk communication in pandemic response

Take­da is con­tin­u­ing to high­light the un­pre­dictable bur­den of hered­i­tary an­gioede­ma in its “Dis­cov­er HAE” cam­paign, in­cor­po­rat­ing more per­son­al sto­ries and im­agery that re­flect pa­tient

Up­stream Bio, a mid-stage res­pi­ra­to­ry drug de­vel­op­er, and CAMP4 Ther­a­peu­tics, a Phase 1 reg­u­la­to­ry RNA start­up, have un­veiled the tar­get­ed price ranges for their ini­tial

For 5 years, retiree George Beitzel went to a Sacramento-area clinic every 2 months so a nurse could give him an injection of the costly